Free Trial
→ Silicon Valley Gold Rush (From Stansberry Research) (Ad) Buy MESO Stock  Free MESO Stock Alerts

Mesoblast (MESO) Financials

Mesoblast logo
$10.92 -0.39 (-3.41%)
Closing price 05/6/2025 03:59 PM Eastern
Extended Trading
$11.38 +0.47 (+4.26%)
As of 07:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Mesoblast

Annual Income Statements for Mesoblast

This table shows Mesoblast's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024
Net Income / (Loss) Attributable to Common Shareholders		 -4.13 -77 -35 -90 -78 -99 -91 -82 -88
Consolidated Net Income / (Loss)		 -4.13 -77 -35 -90 -78 -99 -91 -82 -88
Net Income / (Loss) Continuing Operations		 -4.13 -77 -35 -90 -78 -99 -91 -82 -88
Total Pre-Tax Income 		-91 -90 -66 -99 -87 -100 -92 -82 -88
Total Operating Income		 -119 -90 -75 -80 -75 -118 -98 -89 -79
Total Gross Profit		 -9.72 -33 -10 -20 -19 -67 -65 -66 -56
Total Revenue		 -9.72 -33 -10 -20 -19 -56 -48 -46 -33
Operating Revenue		 -9.72 -33 -10 -20 -19 -56 -48 -46 -33
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 11 17 20 23
Operating Cost of Revenue		 - 0.00 - - - 11 17 20 23
Total Operating Expenses		 109 57 65 60 56 51 33 23 23
Research & Development Expense		 50 59 66 60 56 53 33 27 25
Other Operating Expenses / (Income)		 -2.71 -1.49 -1.31 0.33 -0.32 -1.56 0.54 -4.25 -2.57
Total Other Income / (Expense), net		 28 -0.13 8.71 -18 -13 19 6.81 6.57 -8.91
Other Income / (Expense), net		 28 -0.13 8.71 -18 -13 19 6.81 6.57 -8.91
Income Tax Expense		 -87 -13 -31 -8.96 -9.42 -0.82 -0.24 -0.21 -0.19
Basic Earnings per Share		 ($0.01) ($0.19) ($0.08) ($0.18) ($0.15) ($0.16) ($0.13) ($0.11) ($0.09)
Weighted Average Basic Shares Outstanding		 - - 482.64M 498.63M 583.95M 648.70M 650.45M 814.20M 1.14B
Diluted Earnings per Share		 ($0.01) ($0.19) ($0.08) ($0.18) ($0.15) ($0.16) ($0.13) ($0.11) ($0.09)
Weighted Average Diluted Shares Outstanding		 - - 482.64M 498.63M 583.95M 648.70M 650.45M 814.20M 1.14B
Weighted Average Basic & Diluted Shares Outstanding		 - - 482.64M 498.63M 583.95M 648.70M 650.45M 814.20M 1.14B

Quarterly Income Statements for Mesoblast

No quarterly income statements for Mesoblast are available.

Annual Cash Flow Statements for Mesoblast

This table details how cash moves in and out of Mesoblast's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024
Net Change in Cash & Equivalents		 -28 -35 -7.55 13 77 -113 -76 11 -8.30
Net Cash From Operating Activities		 -102 -101 -85 -87 -83 -113 -67 -79 -68
Net Cash From Continuing Operating Activities		 -102 -101 -85 -87 -83 -113 -67 -79 -68
Net Income / (Loss) Continuing Operations		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income		 -102 -101 -85 -87 -83 -113 -67 -79 -68
Net Cash From Investing Activities		 0.00 0.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities		 0.00 0.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities		 73 60 78 100 163 0.07 -8.83 89 58
Net Cash From Continuing Financing Activities		 73 65 78 100 163 0.07 -8.83 89 58
Repayment of Debt		 0.00 0.00 -0.39 -1.61 -0.51 - -61 -0.57 -12
Issuance of Debt		 0.00 0.00 32 44 0.51 - 52 0.00 0.00
Issuance of Common Equity		 69 62 41 30 145 - 0.21 89 65
Other Financing Activities, net		 4.47 3.31 6.17 27 18 0.07 0.02 1.12 3.82
Cash Interest Received		 1.13 0.48 0.37 0.73 0.55 0.02 0.01 0.80 1.78
Cash Income Taxes Paid		 0.00 0.00 0.03 0.00 0.01 - 0.02 -0.02 -0.00

Quarterly Cash Flow Statements for Mesoblast

No quarterly cash flow statements for Mesoblast are available.

Annual Balance Sheets for Mesoblast

This table presents Mesoblast's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024
Total Assets		 656 692 652 734 745 662 669 669
Total Current Assets		 64 101 63 137 148 70 82 86
Cash & Equivalents		 46 38 50 129 137 60 71 63
Accounts Receivable		 3.74 50 4.06 1.57 4.84 4.40 7.00 21
Prepaid Expenses		 14 13 8.04 5.65 6.50 4.99 3.34 2.55
Plant, Property, & Equipment, net		 1.81 1.08 0.83 2.29 3.02 2.05 1.36 1.11
Plant, Property & Equipment, gross		 1.81 1.08 0.83 2.29 3.02 2.05 1.36 1.11
Total Noncurrent Assets		 590 590 589 595 593 590 586 582
Intangible Assets		 586 585 583 582 581 579 577 576
Other Noncurrent Operating Assets		 1.92 5.68 5.64 13 13 12 9.22 5.85
Total Liabilities & Shareholders' Equity		 656 692 652 731 742 657 661 662
Total Liabilities		 139 146 171 184 163 165 168 189
Total Current Liabilities		 37 24 44 90 94 51 42 73
Short-Term Debt		 - 0.00 14 32 53 5.02 5.95 14
Accounts Payable		 22 19 13 25 20 23 20 7.07
Other Current Liabilities		 15 5.08 7.26 33 21 21 10 48
Total Noncurrent Liabilities		 102 122 127 94 69 114 126 116
Long-Term Debt		 0.00 59 67 57 41 92 103 100
Capital Lease Obligations		 - - 0.00 6.32 8.49 7.09 3.67 1.95
Other Noncurrent Operating Liabilities		 53 43 58 28 17 13 17 11
Total Equity & Noncontrolling Interests		 517 546 481 549 581 497 502 480
Total Preferred & Common Equity		 517 546 481 549 581 497 502 480
Total Common Equity		 517 546 481 549 581 497 502 480
Common Stock		 830 889 910 1,051 1,163 1,165 1,249 1,311
Retained Earnings		 -345 -380 -470 -549 -648 -739 -821 -909
Other Equity Adjustments		 31 37 41 47 66 71 74 78

Quarterly Balance Sheets for Mesoblast

No quarterly balance sheets for Mesoblast are available.

Annual Metrics and Ratios for Mesoblast

This table displays calculated financial ratios and metrics derived from Mesoblast's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% -236.18% 69.15% -101.12% 7.40% -199.29% 14.95% 4.50% 26.67%
EBITDA Growth		 0.00% 0.67% 26.87% -49.68% 11.54% -14.05% 8.07% 10.36% -7.36%
EBIT Growth		 0.00% 0.67% 26.87% -49.68% 11.54% -14.05% 8.07% 10.36% -7.36%
NOPAT Growth		 0.00% 24.26% 17.09% -7.66% 7.19% -58.55% 16.84% 9.89% 10.64%
Net Income Growth		 0.00% -1,761.28% 54.06% -154.46% 13.21% -26.78% 7.55% 10.35% -7.41%
EPS Growth		 0.00% -1,603.54% 60.62% -139.58% 18.83% -10.79% 7.55% 10.35% 15.38%
Operating Cash Flow Growth		 0.00% 1.11% 15.51% -2.30% 5.50% -36.73% 40.25% -17.13% 14.19%
Free Cash Flow Firm Growth		 0.00% 0.00% 71.64% 99.63% -10,424.09% -94.94% 43.88% -5.95% 33.15%
Invested Capital Growth		 0.00% 0.00% 21.03% -9.82% 1.25% 6.07% -0.86% 1.08% -1.82%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 4.54% 85.15% 53.49% 90.93% 89.22% 99.18% 99.74% 99.74% 99.78%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -14.86% -6.64% -17.49% -15.13% -17.48% -16.94% -16.40% -17.91%
Cash Return on Invested Capital (CROIC)		 0.00% -226.89% -29.12% -0.10% -11.38% -21.40% -11.72% -12.40% -8.32%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 0.00% -14.86% -6.64% -17.49% -15.13% -17.48% -16.94% -16.40% -17.91%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -14.86% -6.46% -18.67% -14.19% -17.00% -18.38% -16.32% -18.31%
Net Operating Profit after Tax (NOPAT)		 -83 -63 -52 -56 -52 -83 -69 -62 -55
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.00% -57.61% 130.09% 127.68% -29,713.06% -51.01% 275.61% 40.87% 59.33%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -91 -90 -66 -99 -87 -100 -92 -82 -88
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -91 -90 -66 -99 -87 -100 -92 -82 -88
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 1.07 2.07 1.50 0.58 1.01 0.29
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 1,026.54 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 1.06 2.13 1.53 0.61 1.00 0.35
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.00 0.00 0.11 0.17 0.17 0.18 0.21 0.22 0.24
Long-Term Debt to Equity		 0.00 0.00 0.11 0.14 0.12 0.09 0.20 0.21 0.21
Financial Leverage		 0.00 -0.09 -0.02 0.05 0.00 -0.06 0.02 0.10 0.11
Leverage Ratio		 0.00 1.27 1.27 1.31 1.34 1.31 1.30 1.33 1.36
Compound Leverage Factor		 0.00 1.27 1.27 1.31 1.34 1.31 1.30 1.33 1.36
Debt to Total Capital		 0.00% 0.00% 9.81% 14.46% 14.85% 15.02% 17.26% 18.30% 19.49%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 2.49% 5.03% 7.78% 0.84% 0.97% 2.32%
Long-Term Debt to Total Capital		 0.00% 0.00% 9.81% 11.96% 9.82% 7.24% 16.43% 17.33% 17.17%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 100.00% 90.19% 85.55% 85.15% 84.98% 82.74% 81.70% 80.51%
Debt to EBITDA		 0.00 0.00 -0.90 -0.82 -1.10 -1.03 -1.13 -1.37 -1.32
Net Debt to EBITDA		 0.00 0.00 -0.33 -0.31 0.38 0.34 -0.47 -0.50 -0.61
Long-Term Debt to EBITDA		 0.00 0.00 -0.90 -0.68 -0.73 -0.50 -1.08 -1.30 -1.16
Debt to NOPAT		 0.00 0.00 -1.14 -1.44 -1.83 -1.24 -1.51 -1.81 -2.10
Net Debt to NOPAT		 0.00 0.00 -0.41 -0.55 0.64 0.41 -0.63 -0.66 -0.96
Long-Term Debt to NOPAT		 0.00 0.00 -1.14 -1.20 -1.21 -0.60 -1.43 -1.72 -1.85
Altman Z-Score		 0.00 0.00 0.00 0.29 2.31 1.56 -1.01 -0.30 -1.92
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 0.00 1.73 4.21 1.41 1.51 1.57 1.36 1.95 1.18
Quick Ratio		 0.00 1.35 3.67 1.23 1.45 1.50 1.26 1.87 1.15
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -532 -151 -0.56 -59 -114 -64 -68 -45
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.48 0.81 0.93 1.69
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 759.20 450.52 392.03 215.86
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 0.00 469 568 512 518 550 545 551 541
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 0.00 469 99 -56 6.38 31 -4.75 5.88 -10
Enterprise Value (EV)		 0.00 0.00 0.00 543 1,102 839 331 550 192
Market Capitalization		 0.00 0.00 0.00 513 1,136 874 288 509 139
Book Value per Share		 $0.00 $0.00 $1.13 $1.00 $1.10 $1.00 $0.77 $0.77 $0.59
Tangible Book Value per Share		 $0.00 $0.00 ($0.08) ($0.21) ($0.06) $0.00 ($0.13) ($0.12) ($0.12)
Total Capital		 0.00 517 605 562 645 684 601 614 597
Total Debt		 0.00 0.00 59 81 96 103 104 112 116
Total Long-Term Debt		 0.00 0.00 59 67 63 50 99 106 102
Net Debt		 0.00 -46 22 31 -34 -34 43 41 53
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -19 39 -18 -50 -30 -37 -26 -36
Debt-free Net Working Capital (DFNWC)		 0.00 27 77 32 79 107 23 46 27
Net Working Capital (NWC)		 0.00 27 77 18 46 54 18 40 13
Net Nonoperating Expense (NNE)		 -79 14 -17 34 26 16 22 20 32
Net Nonoperating Obligations (NNO)		 0.00 -48 22 31 -31 -32 48 49 60
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.61) ($1.45) ($1.18) ($1.31) $0.00 ($0.89) ($0.09)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 60.33M 62.33M 72.99M 81.09M 0.00 101.78M 1.14B
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.61) ($1.45) ($1.18) ($1.31) ($1.13) ($0.89) ($0.09)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 60.33M 62.33M 72.99M 81.09M 81.31M 101.78M 1.14B
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($0.61) ($1.45) ($1.18) ($1.31) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 60.33M 62.33M 72.99M 81.09M 81.31M 101.78M 1.14B
Normalized Net Operating Profit after Tax (NOPAT)		 -40 -63 -52 -56 -52 -83 -69 -62 -55
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Mesoblast

No quarterly metrics and ratios for Mesoblast are available.

Frequently Asked Questions About Mesoblast's Financials

When does Mesoblast's fiscal year end?

According to the most recent income statement we have on file, Mesoblast's financial year ends in June. Their financial year 2024 ended on June 30, 2024.

How has Mesoblast's net income changed over the last 8 years?

Mesoblast's net income appears to be on an upward trend, with a most recent value of -$87.96 million in 2024, rising from -$4.13 million in 2016. The previous period was -$81.89 million in 2023. See Mesoblast's forecast for analyst expectations on what’s next for the company.

What is Mesoblast's operating income?
Mesoblast's total operating income in 2024 was -$79.23 million, based on the following breakdown:
  • Total Gross Profit: -$56.45 million
  • Total Operating Expenses: $22.78 million
How has Mesoblast revenue changed over the last 8 years?

Over the last 8 years, Mesoblast's total revenue changed from -$9.72 million in 2016 to -$33.44 million in 2024, a change of 244.2%.

How much debt does Mesoblast have?

Mesoblast's total liabilities were at $188.80 million at the end of 2024, a 12.7% increase from 2023, and a 35.9% increase since 2017.

How much cash does Mesoblast have?

In the past 7 years, Mesoblast's cash and equivalents has ranged from $37.76 million in 2018 to $136.88 million in 2021, and is currently $62.96 million as of their latest financial filing in 2024.

How has Mesoblast's book value per share changed over the last 8 years?

Over the last 8 years, Mesoblast's book value per share changed from 0.00 in 2016 to 0.59 in 2024, a change of 59.0%.


Related Companies

This page (NASDAQ:MESO) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...
Crypto 101 Media | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Musk's warning signal: Prepare before the cascade begins
When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...
InvestorPlace | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored